These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25459142)

  • 1. The link between oral contraceptive use and prevalence in autism spectrum disorder.
    Strifert K
    Med Hypotheses; 2014 Dec; 83(6):718-25. PubMed ID: 25459142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epigenetic basis for autism spectrum disorder risk and oral contraceptive use.
    Strifert K
    Med Hypotheses; 2015 Dec; 85(6):1006-11. PubMed ID: 26364046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental contributors to modulation of brain estrogen signaling and male gender bias in autism: A reply to the oral contraceptive use hypothesis by Strifert (2015).
    Fluegge K
    Med Hypotheses; 2017 Jul; 104():178-181. PubMed ID: 28673581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002.
    ;
    MMWR Surveill Summ; 2007 Feb; 56(1):12-28. PubMed ID: 17287715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000.
    ;
    MMWR Surveill Summ; 2007 Feb; 56(1):1-11. PubMed ID: 17287714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The possibility of prenatal diagnosis of autism spectrum disorder].
    Vanya M; Szücs S; Szili K; Vetró Á; Bártfai G
    Psychiatr Hung; 2015; 30(3):303-7. PubMed ID: 26471032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke in users of low-dose oral contraceptives.
    Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
    N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of drugs and intrauterine devices for birth control.
    Meeker CI
    N Engl J Med; 1969 May; 280(19):1058-60. PubMed ID: 4180710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors in autism: Thinking outside the brain.
    Matelski L; Van de Water J
    J Autoimmun; 2016 Feb; 67():1-7. PubMed ID: 26725748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic Disparities and Prevalence of Autism Spectrum Disorders and Intellectual Disability.
    Delobel-Ayoub M; Ehlinger V; Klapouszczak D; Maffre T; Raynaud JP; Delpierre C; Arnaud C
    PLoS One; 2015; 10(11):e0141964. PubMed ID: 26540408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autism spectrum disorders in young children: effect of changes in diagnostic practices.
    Nassar N; Dixon G; Bourke J; Bower C; Glasson E; de Klerk N; Leonard H
    Int J Epidemiol; 2009 Oct; 38(5):1245-54. PubMed ID: 19737795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History (of oral contraceptives).
    Fam Plann Inf Serv; 1978 Feb; 1(1):4-5. PubMed ID: 12308937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal contraceptives and autism epidemics.
    Donhauser J
    Med Hypotheses; 2020 Aug; 141():109729. PubMed ID: 32304984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advantages and risks of hormonal contraception].
    Mall-Haefeli M
    Fortschr Med; 1982 Apr; 100(16):723-8. PubMed ID: 7084860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the prevalence of stimulus overselectivity in children with ASD.
    Rieth SR; Stahmer AC; Suhrheinrich J; Schreibman L
    J Appl Behav Anal; 2015; 48(1):71-84. PubMed ID: 25418837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.